CONTRACT FOR RESEARCH FUNDING: HEALTH RESEARCH COUNCIL OF NEW ZEALANDResearch Funding Agreement • September 2nd, 2021
FIRST AMENDMENT TO RESEARCH FUNDING AGREEMENT This First Amendment To Research Funding Agreement (the "Amendment"), effective as of March 1, 2001, is entered into by and between Stanislaw R. Burzynski, M.D., PhD. ("Dr. Burzynski") and Burzynski...Research Funding Agreement • May 2nd, 2001 • Burzynski Research Institute Inc • In vitro & in vivo diagnostic substances • Texas
Annex I – Template of the Research Funding AgreementResearch Funding Agreement • January 18th, 2024
Note: This template of the Research Funding Agreement is only for information at this stage. It shall be signed by the Bial Foundation, the Principal Investigator and the Host Entity afterwards, in case the project is selected for funding and all other necessary conditions and requirements are met.
Research Funding AgreementResearch Funding Agreement • May 5th, 2020 • Western Australia
Institution: The Minister for Health is incorporated as the board of [INSERT NAME OF RELEVANT HOSPITAL (S)] under s7 of the Hospitals and Health Services Act 1927 (WA) and has delegated all the powers and duties as such to the Director General of Health
Agreements are loosely in the format of this template. Project specific requirements may change agreement details.Research Funding Agreement • August 14th, 2024
This Research Funding Agreement (the “Agreement”) is made by and between the Focused Ultrasound Foundation, a 501(c)(3) organization and public charity having its principal place of business at 1230 Cedars Court, Suite 206, Charlottesville, VA 22903 (hereinafter referred to as the “Foundation”) and Institution, an EDUCATIONAL INSTITUTION/CORPORATION having its principal place of business at BUSINESS ADDRESS (hereinafter referred to as the “Institution”), and PI_Salutation«PI_FirstName PI_LastName, PI_Credentials having a professional affiliation with Institution (the “Investigator”), and is to be effective as of the date of the last signature below (the “Effective Date”).
RESEARCH FUNDING AGREEMENTResearch Funding Agreement • July 2nd, 2013
A The Commission provides research grants to facilitate research and education about matters relevant to natural disaster damage, methods of preventing and reducing natural disaster damage and the insurance provided under the Earthquake Commission Act 1993.
RESEARCH FUNDING AGREEMENTResearch Funding Agreement • February 22nd, 2024
The UNIVERSITY OF THE PHILIPPINES, the national university of the Republic of the Philippines, created and operating under Act No. 1870 and Republic Act No. 9500, represented by DR. MICHAEL L. TEE, Professor and Chancellor of the University of the Philippines Manila, representing [name of college] with office address at the 8th Floor, RCB Building, Philippine General Hospital, Manila, from now on referred to as the “UNIVERSITY;”
RESEARCH FUNDING AGREEMENTResearch Funding Agreement • December 4th, 2018 • England and Wales
The Funders and the Researchers named above are the Parties to the Agreement. For the avoidance of doubt, any Co-Funders named in Schedule C but not named above and any Co-Researchers named in Schedule D but not named above are not Parties to this Agreement.
RESEARCH FUNDING AGREEMENTResearch Funding Agreement • December 4th, 2018 • England and Wales
Such of Annex 2 (Intellectual Property Rights vested in the Researcher, page 44) or Annex 3 (Intellectual Property Rights retained by AHDB, page
RESEARCH FUNDING AGREEMENT PROJECT TITLE PHA PROJECT NUMBER 20XX-XXX BETWEENResearch Funding Agreement • July 25th, 2023
Poultry Hub Australia (PHA) is located at the University of New England (UNE) in Armidale, NSW While PHA sits within the grounds of UNE, it is a semi-autonomous body with authority to manage its own branding, contracting, financial delegation, and personnel management.
RESEARCH FUNDING AGREEMENTResearch Funding Agreement • August 24th, 2022 • Maine
This Research Funding Agreement (“Agreement”) is entered into as of the date of last signature below (“Effective Date”) between The Jackson Laboratory, a Maine non-profit corporation with a principal place of business at 600 Main Street, Bar Harbor, Maine 04609 (“Jackson”) and (“Institution”).
AMENDMENT NO. 1 to the RESEARCH FUNDING AGREEMENT by and between Affimed Therapeutics AG and The Leukemia & Lymphoma SocietyResearch Funding Agreement • June 27th, 2014 • Affimed Therapeutics B.V. • Pharmaceutical preparations
This Amendment (the “Amendment”) is made as of April 29th, 2014 (the “Amendment Effective Date”), by and between The Leukemia and Lymphoma Society, a New York nonprofit corporation with its principal place of business at 1311 Mamaroneck Avenue, White Plains, New York 10605, United States of America (“LLS”) and Affimed Therapeutics AG, a German limited liability company with its principal place of business at Im Neuenheimer Feld 582, 69120 Heidelberg, Germany (“Affimed”). LLS and Affimed are hereinafter referred to individually as the “Party” and together as the “Parties”.
Research Funding AgreementResearch Funding Agreement • November 14th, 2020 • Ontario
WHEREAS the Canadian Foundation for Governance Research has created the Robert Bertram Doctoral Research Awards program to support the research of the country’s most promising doctoral students at universities across Canada who are studying corporate governance issues and to build Canada’s corporate governance research capacity by encouraging the next generation of young scholars;
RESEARCH FUNDING AGREEMENTResearch Funding Agreement • July 7th, 2020
UKZN has submitted a proposal with project title : XXX to XXX (Funder details) and XXX (Funder details) is desirous of having UKZN execute the project.
ITEM 8 ILLAWARRA REGIONAL INFORMATION SERVICE RESEARCH FUNDING AGREEMENT - 1 JULY 2017 TO 30 JUNE 2021Research Funding Agreement • June 16th, 2017
This report proposes a new four year funding agreement between Wollongong City Council and IRIS, to commence on 1 July 2017. It is proposed the new funding agreement will include two biennial community surveys as well as Omnibus surveys, online surveys, research support and in-house training.
ContractResearch Funding Agreement • April 26th, 2023
Research funding from Chinese companies and institutions, 2017/18 - 2020/21 Funder Project Title Aircraft Strength Research Institute, AVIC AVIC-ASRI Research Agreement AVIC Manufacturing Technology Institute AVIC Centre for Structural Design & Manufacture Beijing Aeronautical Science & Technology Research COMAC-Imperial Research Centre for wing technology for commercial aircraft Beijing Institute of Aeronautical Materials (BIAM) AVIC Centre for Materials Characterisation, Processing and Modelling BGP Inc IMPERIAL CENTRE FOR RESERVOIR GEOPHYSICS China National Technical Import & Export Corporati Formation and evolution of intra-cratonic rift from Late Sinian to Early Cambrian in the Sichuan Basin, South China China Petrochemical Technology Company Limited Centre for Reservoir Geophysics China Petroleum and Chemical Corporation (SINOPEC) RESOURCE GEOPHYSICS ACADEMY China University of Petroleum Sponsorship of Research Associate ChinaRocket Co., LTD CALT Lab (CASC) CNOOC China Limited
ContractResearch Funding Agreement • June 14th, 2021
RESEARCH FUNDING AGREEMENT Dated: …………………………………… Parties: (1) The EARTHQUAKE COMMISSIONa Crown entity continuing under the Earthquake Commission Act 1993 (the Commission) (2) ……………………………………………………………………………………………………………… (the Host Institution) Principal Investigator/Supervising Researcher: ………………………………………………………………………… (the Researcher) Project for which funding is granted: “…………………………………………………………………………………………………………………….”(identified as EQC Project No ) (the Project)as described in the attached research proposal dated submitted by the Researcher, and whichforms part of this Research Funding Agreement. Background: • The Commission provides research grants to facilitate research and education about matters relevant tonatural disaster damage, methods of preventing and reducing natural disaster damage and the insurance provided under the Earthquake Commission Act 1993. • The Commission has approved a research grant for the attached research proposal, provisional upon theCommission, the Host
ContractResearch Funding Agreement • December 16th, 2015
Is the Research Funding Agreement, as found on the NASFM website, an example of the agreement that would be presented upon award to the awardee with NASFM and NASFM Foundation as sponsors? If it is an example of the agreement presented upon award, would it be open to negotiation for certain clauses?
RESEARCH FUNDING AGREEMENT by and between THE SCRIPPS RESEARCH INSTITUTE a California nonprofit public benefit corporation and ChromaPharma, Inc. A Nevada corporation RESEARCH FUNDING AGREEMENTResearch Funding Agreement • August 10th, 2017 • ChromaDex Corp. • Medicinal chemicals & botanical products • California
This Agreement is entered into this 5th day of June, 2017 (the “Effective Date”), by and between The Scripps Research Institute, a California nonprofit public benefit corporation located at 10550 North Torrey Pines Road, La Jolla, California 92037 ("TSRI"), and ChromaPharma, Inc., a Nevada for-profit corporation located at 10005 Muirlands Blvd., Suite G, Irvine, CA 92618 USA ("Sponsor"), with respect to the facts set forth below.
FIRST AMENDMENT TO RESEARCH FUNDING AGREEMENTResearch Funding Agreement • March 27th, 2003 • Sangamo Biosciences Inc • Biological products, (no disgnostic substances)
This is the First Amendment to the Research Funding Agreement (the “Agreement”) between Sangamo BioSciences, Inc. (“Sangamo”) and Baxter Healthcare Corporation (“Baxter”), dated January 11, 2000. This First Amendment shall be effective as of November 14, 2002.
SECOND AMENDMENT TO THE RESEARCH FUNDING AGREEMENTResearch Funding Agreement • June 1st, 2004 • Burzynski Research Institute Inc • In vitro & in vivo diagnostic substances
This Second Amendment to the Research Funding Agreement is dated as of February 29, 2004. On or about March 1, 2001, Dr. Stanislaw R. Burzynski and the Burzynski Research Institute, Inc. (BRI) entered into a First Amendment to the Research Funding Agreement, under which funding agreement, inter alia, Dr. Burzynski agreed to fund the research undertaken by BRI.
Cancer Drug Development Forum (CDDF) Monday 25th April 2022Research Funding Agreement • April 22nd, 2022
Research Funding AgreementResearch Funding Agreement • May 6th, 2021
THE STATE OF WESTERN AUSTRALIA acting by and through the Department of Jobs, Tourism, Science and Innovation (“Department”) of Level 11, 1 William Street, Perth, Western Australia 6000
RESEARCH FUNDING AGREEMENT by and between Affimed Therapeutics AG and The Leukemia & Lymphoma SocietyResearch Funding Agreement • June 27th, 2014 • Affimed Therapeutics B.V. • Pharmaceutical preparations • New York
This Agreement (the “Agreement”) is made as of August 26th, 2013 (the “Effective Date”), by and between The Leukemia and Lymphoma Society, a New York nonprofit corporation with its principal place of business at 1311 Mamaroneck Avenue, White Plains, New York 10605, United States of America (“LLS”) and Affimed Therapeutics AG, a German limited liability company with its principal place of business at Im Neuenheimer Feld 582, 69120 Heidelberg, Germany (“Affimed”). LLS and Affimed are sometimes hereinafter referred to individually as the “Party” and together as the “Parties”.
Biennial Grants Programme Research Funding AgreementResearch Funding Agreement • April 9th, 2019
The Commission provides research grants to facilitate research and education about matters relevant to natural disaster damage, methods of preventing and reducing natural disaster damage and the insurance provided under the Earthquake Commission Act 1993.
RECITALSResearch Funding Agreement • March 14th, 2000 • Sangamo Biosciences Inc • Services-commercial physical & biological research • California
DisclosuresResearch Funding Agreement • May 26th, 2017
CONTRACT FOR RESEARCH FUNDING: HEALTH RESEARCH COUNCIL OF NEW ZEALANDResearch Funding Agreement • August 9th, 2016
THIRD SCHEDULE - RESEARCH ACTIVITY DETAILS AND FUNDING FOURTH SCHEDULE - RESEARCH OBJECTIVES INCLUDING MILESTONES FIFTH SCHEDULE - INTELLECTUAL PROPERTY RIGHTS
ContractResearch Funding Agreement • May 28th, 2020 • New York
Award Amount: $100,000 payable to Host Institution (together with any interest income earned by Host Institution on Research Funding funds, the “Research Funding”)
AGREEMENT FOR RESEARCH FUNDING BY WAY OF CONTRIBUTION TO THE EXPENSES SUSTAINED FOR RESEARCH PROJECTS AND PROFESSIONAL TRAINING FALLING UNDER NATIONAL PROGRAMMES TO BE DRAWN FROM THE SPECIAL FUND FOR APPLIED RESEARCHResearch Funding Agreement • July 7th, 2003 • Vicuron Pharmaceuticals Inc • Pharmaceutical preparations
Mr. Giuseppe Colona, born in Rome on 7/8/1942, with an address for service in his official capacity at Viale dell'Arte 25, Rome, acting in his capacity as an Executive Officer representing "SANPAOLO IMI S.p.A"—a bank entered at no. 5084.9.0 in the Roll of Banks (Albo delle Banche) and parent company of the SANPAOLO IMI Group, entered at no. 1025.6, in the Roll of Banking Groups (Albo dei Gruppi Bancari), member of the Italian Interbank Deposit Protection Fund (Fondo Interbancario di Tutela dei Depositi), with registered offices in Turin at Piazza San Carlo 156, as well as secondary, fixed representative offices in Rome at Viale dell'Arte 25, fully paid-up share capital of 3,931,250,954.40 euro, Tax and Turin Companies Registry no. 06210280019—by virtue of powers of attorney for the stipulation of deeds and agreements, notarised on 3 October 2000 by Notary Daniele Bazzoni of Turin under file no. 79019, conferred on him by the Managing Director and legal representative of the aforesaid c
RESEARCH FUNDING AGREEMENTResearch Funding Agreement • October 15th, 2003 • Burzynski Research Institute Inc • In vitro & in vivo diagnostic substances
THIS AGREEMENT effective as of March 1,1997, by and between Stanislaw R. Burzynski, M.D. Ph.D (hereinafter “SRB”) having his principal place of business at 12000 Richmond Avenue, Houston, Texas and the Burzynski Research Institute, Inc., a Delaware Corporation (“BRI”) having its principal place of business at 12000 Richmond Avenue, Houston Texas hereby agree as follows:
Bullying at school: Agreement between caregivers’ and children’s perceptionResearch Funding Agreement • November 8th, 2016
RESEARCH FUNDING AGREEMENTResearch Funding Agreement • September 28th, 2023
WHEREAS, COMPANY has agreed to provide funding and support to SPONSOR and its employee, the PRINCIPAL INVESTIGATOR, to conduct a clinical investigation as sponsor-investigator according to a
THIRD AMENDMENT TO THE RESEARCH FUNDING AGREEMENTResearch Funding Agreement • May 29th, 2007 • Burzynski Research Institute Inc • In vitro & in vivo diagnostic substances
On or about February 29, 2004, Dr. Stanislaw R. Burzynski and the Burzynski Research Institute, Inc. (BRI) entered into a Second Amendment to the Research Funding Agreement, under which funding agreement, inter alia, Dr. Burzynski agreed to fund the research undertaken by BRI.
AMENDED AND RESTATED RESEARCH FUNDING AGREEMENTResearch Funding Agreement • May 22nd, 2023 • Burzynski Research Institute Inc • In vitro & in vivo diagnostic substances
THIS AMENDED AND RESTATED AGREEMENT (the "Agreement”) effective as of May 22, 2023, by and between Stanislaw R. Burzynski, M.D. Ph.D (hereinafter "SRB") with offices at 9432 Katy Freeway, Suite 200, Houston, Texas 77055 and Burzynski Research Institute, Inc. (the "Company"), a Delaware corporation with offices located at 9432 Katy Freeway, Suite 200, Houston, Texas 77055:
